Compare Stocks

3 / 10
Try these comparisons:

Stock Comparison

OEC vs CBT vs KRO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
OEC
Orion Engineered Carbons S.A.

Chemicals - Specialty

Basic MaterialsNYSE • LU
Market Cap$461M
5Y Perf.-25.9%
CBT
Cabot Corporation

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$4.30B
5Y Perf.+130.7%
KRO
Kronos Worldwide, Inc.

Chemicals - Specialty

Basic MaterialsNYSE • US
Market Cap$871M
5Y Perf.-22.4%

OEC vs CBT vs KRO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
OEC logoOEC
CBT logoCBT
KRO logoKRO
IndustryChemicals - SpecialtyChemicals - SpecialtyChemicals - Specialty
Market Cap$461M$4.30B$871M
Revenue (TTM)$1.79B$3.58B$1.88B
Net Income (TTM)$-89M$285M$-134M
Gross Margin19.1%24.8%10.1%
Operating Margin4.5%15.7%-3.1%
Forward P/E36.4x13.2x
Total Debt$980M$1.22B$577M
Cash & Equiv.$61M$258M$37M

OEC vs CBT vs KROLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

OEC
CBT
KRO
StockMay 20May 26Return
Orion Engineered Ca… (OEC)10074.1-25.9%
Cabot Corporation (CBT)100230.7+130.7%
Kronos Worldwide, I… (KRO)10077.6-22.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: OEC vs CBT vs KRO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CBT leads in 6 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Kronos Worldwide, Inc. is the stronger pick specifically for growth and revenue expansion. As sector peers, any of these can serve as alternatives in the same allocation.
OEC
Orion Engineered Carbons S.A.
The Secondary Option

OEC plays a supporting role in this comparison — it may shine differently against other peers.

Best for: basic materials exposure
CBT
Cabot Corporation
The Income Pick

CBT carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.

  • Dividend streak 4 yrs, beta 0.78, yield 2.1%
  • Lower volatility, beta 0.78, Low D/E 71.3%, current ratio 1.61x
  • Beta 0.78, yield 2.1%, current ratio 1.61x
Best for: income & stability and sleep-well-at-night
KRO
Kronos Worldwide, Inc.
The Growth Play

KRO is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth -1.5%, EPS growth -228.0%, 3Y rev CAGR -1.2%
  • 121.1% 10Y total return vs CBT's 115.6%
  • -1.5% revenue growth vs CBT's -7.0%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthKRO logoKRO-1.5% revenue growth vs CBT's -7.0%
ValueCBT logoCBTBetter valuation composite
Quality / MarginsCBT logoCBT8.0% margin vs KRO's -7.1%
Stability / SafetyCBT logoCBTBeta 0.78 vs KRO's 1.57, lower leverage
DividendsCBT logoCBT2.1% yield, 4-year raise streak, vs KRO's 2.6%
Momentum (1Y)CBT logoCBT+16.2% vs OEC's -27.8%
Efficiency (ROA)CBT logoCBT7.4% ROA vs KRO's -9.4%, ROIC 17.4% vs -1.9%

OEC vs CBT vs KRO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

OECOrion Engineered Carbons S.A.
FY 2025
Rubber
65.8%$1.2B
Specialties
34.2%$619M
CBTCabot Corporation
FY 2025
Reinforcement Materials
65.2%$2.3B
Performance Chemicals
34.8%$1.3B
KROKronos Worldwide, Inc.
FY 2014
Point Of Destination
100.0%$1.7B

OEC vs CBT vs KRO — Financial Metrics

Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCBTLAGGINGKRO

Income & Cash Flow (Last 12 Months)

CBT leads this category, winning 5 of 6 comparable metrics.

CBT is the larger business by revenue, generating $3.6B annually — 2.0x OEC's $1.8B. CBT is the more profitable business, keeping 8.0% of every revenue dollar as net income compared to KRO's -7.1%. On growth, KRO holds the edge at +4.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricOEC logoOECOrion Engineered …CBT logoCBTCabot CorporationKRO logoKROKronos Worldwide,…
RevenueTrailing 12 months$1.8B$3.6B$1.9B
EBITDAEarnings before interest/tax$180M$731M-$9M
Net IncomeAfter-tax profit-$89M$285M-$134M
Free Cash FlowCash after capex$68M$459M$35M
Gross MarginGross profit ÷ Revenue+19.1%+24.8%+10.1%
Operating MarginEBIT ÷ Revenue+4.5%+15.7%-3.1%
Net MarginNet income ÷ Revenue-5.0%+8.0%-7.1%
FCF MarginFCF ÷ Revenue+3.8%+12.8%+1.9%
Rev. Growth (YoY)Latest quarter vs prior year-3.8%-3.4%+4.1%
EPS Growth (YoY)Latest quarter vs prior year-2.1%-23.1%-126.1%
CBT leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

OEC leads this category, winning 3 of 6 comparable metrics.

On an enterprise value basis, OEC's 5.9x EV/EBITDA is more attractive than KRO's 42.5x.

MetricOEC logoOECOrion Engineered …CBT logoCBTCabot CorporationKRO logoKROKronos Worldwide,…
Market CapShares × price$461M$4.3B$871M
Enterprise ValueMkt cap + debt − cash$1.4B$5.3B$1.4B
Trailing P/EPrice ÷ TTM EPS-6.61x13.69x-7.89x
Forward P/EPrice ÷ next-FY EPS est.36.36x13.23x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple5.91x6.79x42.51x
Price / SalesMarket cap ÷ Revenue0.26x1.16x0.47x
Price / BookPrice ÷ Book value/share1.20x2.62x1.16x
Price / FCFMarket cap ÷ FCF9.19x11.01x
OEC leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

CBT leads this category, winning 7 of 9 comparable metrics.

CBT delivers a 16.8% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-22 for OEC. CBT carries lower financial leverage with a 0.71x debt-to-equity ratio, signaling a more conservative balance sheet compared to OEC's 2.55x. On the Piotroski fundamental quality scale (0–9), CBT scores 6/9 vs OEC's 4/9, reflecting solid financial health.

MetricOEC logoOECOrion Engineered …CBT logoCBTCabot CorporationKRO logoKROKronos Worldwide,…
ROE (TTM)Return on equity-21.8%+16.8%-17.0%
ROA (TTM)Return on assets-4.6%+7.4%-9.4%
ROICReturn on invested capital+5.5%+17.4%-1.9%
ROCEReturn on capital employed+7.8%+21.3%-2.2%
Piotroski ScoreFundamental quality 0–9465
Debt / EquityFinancial leverage2.55x0.71x0.77x
Net DebtTotal debt minus cash$919M$957M$540M
Cash & Equiv.Liquid assets$61M$258M$37M
Total DebtShort + long-term debt$980M$1.2B$577M
Interest CoverageEBIT ÷ Interest expense-0.14x14.72x-2.32x
CBT leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CBT leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in CBT five years ago would be worth $14,375 today (with dividends reinvested), compared to $3,861 for OEC. Over the past 12 months, CBT leads with a +16.2% total return vs OEC's -27.8%. The 3-year compound annual growth rate (CAGR) favors CBT at 7.5% vs OEC's -29.3% — a key indicator of consistent wealth creation.

MetricOEC logoOECOrion Engineered …CBT logoCBTCabot CorporationKRO logoKROKronos Worldwide,…
YTD ReturnYear-to-date+56.3%+23.6%+70.1%
1-Year ReturnPast 12 months-27.8%+16.2%+4.3%
3-Year ReturnCumulative with dividends-64.7%+24.1%+5.5%
5-Year ReturnCumulative with dividends-61.4%+43.8%-40.9%
10-Year ReturnCumulative with dividends-23.8%+115.6%+121.1%
CAGR (3Y)Annualised 3-year return-29.3%+7.5%+1.8%
CBT leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

CBT leads this category, winning 2 of 2 comparable metrics.

CBT is the less volatile stock with a 0.78 beta — it tends to amplify market swings less than KRO's 1.57 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBT currently trades 97.4% from its 52-week high vs OEC's 67.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricOEC logoOECOrion Engineered …CBT logoCBTCabot CorporationKRO logoKROKronos Worldwide,…
Beta (5Y)Sensitivity to S&P 5001.39x0.78x1.57x
52-Week HighHighest price in past year$12.10$84.60$7.90
52-Week LowLowest price in past year$4.35$58.33$4.08
% of 52W HighCurrent price vs 52-week peak+67.8%+97.4%+95.8%
RSI (14)Momentum oscillator 0–10078.063.969.2
Avg Volume (50D)Average daily shares traded612K371K343K
CBT leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — CBT and KRO each lead in 1 of 2 comparable metrics.

Analyst consensus: OEC as "Buy", CBT as "Buy", KRO as "Hold". Consensus price targets imply -5.4% upside for CBT (target: $78) vs -33.9% for KRO (target: $5). For income investors, KRO offers the higher dividend yield at 2.64% vs OEC's 1.02%.

MetricOEC logoOECOrion Engineered …CBT logoCBTCabot CorporationKRO logoKROKronos Worldwide,…
Analyst RatingConsensus buy/hold/sellBuyBuyHold
Price TargetConsensus 12-month target$5.88$78.00$5.00
# AnalystsCovering analysts14157
Dividend YieldAnnual dividend ÷ price+1.0%+2.1%+2.6%
Dividend StreakConsecutive years of raises340
Dividend / ShareAnnual DPS$0.08$1.77$0.20
Buyback YieldShare repurchases ÷ mkt cap+5.4%+3.9%0.0%
Evenly matched — CBT and KRO each lead in 1 of 2 comparable metrics.
Key Takeaway

CBT leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). OEC leads in 1 (Valuation Metrics). 1 tied.

Best OverallCabot Corporation (CBT)Leads 4 of 6 categories
Loading custom metrics...

OEC vs CBT vs KRO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is OEC or CBT or KRO a better buy right now?

For growth investors, Kronos Worldwide, Inc.

(KRO) is the stronger pick with -1. 5% revenue growth year-over-year, versus -7. 0% for Cabot Corporation (CBT). Cabot Corporation (CBT) offers the better valuation at 13. 7x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate Orion Engineered Carbons S. A. (OEC) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — OEC or CBT or KRO?

On forward P/E, Cabot Corporation is actually cheaper at 13.

2x.

03

Which is the better long-term investment — OEC or CBT or KRO?

Over the past 5 years, Cabot Corporation (CBT) delivered a total return of +43.

8%, compared to -61. 4% for Orion Engineered Carbons S. A. (OEC). Over 10 years, the gap is even starker: KRO returned +121. 1% versus OEC's -23. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — OEC or CBT or KRO?

By beta (market sensitivity over 5 years), Cabot Corporation (CBT) is the lower-risk stock at 0.

78β versus Kronos Worldwide, Inc. 's 1. 57β — meaning KRO is approximately 101% more volatile than CBT relative to the S&P 500. On balance sheet safety, Cabot Corporation (CBT) carries a lower debt/equity ratio of 71% versus 3% for Orion Engineered Carbons S. A. — giving it more financial flexibility in a downturn.

05

Which is growing faster — OEC or CBT or KRO?

By revenue growth (latest reported year), Kronos Worldwide, Inc.

(KRO) is pulling ahead at -1. 5% versus -7. 0% for Cabot Corporation (CBT). On earnings-per-share growth, the picture is similar: Cabot Corporation grew EPS -10. 4% year-over-year, compared to -263. 2% for Orion Engineered Carbons S. A.. Over a 3-year CAGR, KRO leads at -1. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — OEC or CBT or KRO?

Cabot Corporation (CBT) is the more profitable company, earning 8.

9% net margin versus -6. 0% for Kronos Worldwide, Inc. — meaning it keeps 8. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBT leads at 16. 7% versus -1. 7% for KRO. At the gross margin level — before operating expenses — CBT leads at 25. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is OEC or CBT or KRO more undervalued right now?

On forward earnings alone, Cabot Corporation (CBT) trades at 13.

2x forward P/E versus 36. 4x for Orion Engineered Carbons S. A. — 23. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CBT: -5. 4% to $78. 00.

08

Which pays a better dividend — OEC or CBT or KRO?

All stocks in this comparison pay dividends.

Kronos Worldwide, Inc. (KRO) offers the highest yield at 2. 6%, versus 1. 0% for Orion Engineered Carbons S. A. (OEC).

09

Is OEC or CBT or KRO better for a retirement portfolio?

For long-horizon retirement investors, Cabot Corporation (CBT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

78), 2. 1% yield, +115. 6% 10Y return). Kronos Worldwide, Inc. (KRO) carries a higher beta of 1. 57 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CBT: +115. 6%, KRO: +121. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between OEC and CBT and KRO?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: OEC is a small-cap quality compounder stock; CBT is a small-cap deep-value stock; KRO is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

OEC

Stable Dividend Mega-Cap

  • Sector: Basic Materials
  • Market Cap > $100B
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

CBT

Income & Dividend Stock

  • Sector: Basic Materials
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 0.8%
Run This Screen
Stocks Like

KRO

Income & Dividend Stock

  • Sector: Basic Materials
  • Market Cap > $100B
  • Dividend Yield > 1.0%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform OEC and CBT and KRO on the metrics below

Revenue Growth>
%
(OEC: -3.8% · CBT: -3.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.